Get the Stockscreener App
1.45
18.85%
0.23
After Hours:
1.41
-0.04
-2.76%
Osr Holdings Inc stock is traded at $1.45, with a volume of 455.99K.
It is up +18.85% in the last 24 hours and up +5.84% over the past month.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
See More
Previous Close:
$1.22
Open:
$1.26
24h Volume:
455.99K
Relative Volume:
0.15
Market Cap:
$27.96M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+25.00%
1M Performance:
+5.84%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$1.18
$1.61
1-Week Range:
$1.05
$1.61
52-Week Range:
$1.02
$6.95
Osr Holdings Inc Stock (OSRH) Company Profile
Name
Osr Holdings Inc
Sector
Industry
Phone
425-635-7700
Address
10900 NE 4TH STREET, SUITE 2300, BELLEVUE
Compare OSRH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OSRH
Osr Holdings Inc
|
1.45 | 22.36M | 0 | 0 | 0 | 0.00 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Osr Holdings Inc Stock (OSRH) Latest News
OSR Holdings to Explore Development of Blockchain-Based Security Token With BCM Europe - marketscreener.com
OSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-Based OSRH Token - Quantisnow
OSR Holdings, Inc. SEC 10-Q Report - TradingView
OSR Holdings Secures $1.1M Note Purchase Agreement - TipRanks
Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics - PR Newswire
Strategic Moves Drive Stock Gains For OSR, Lianhe Sowell, And Aptevo - Finimize
OSR Holdings Inc’s Market Journey: Closing Weak at 1.53, Down -21.54 - DWinneX
Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology - digitalmore.co
Game-Changing Osteoarthritis Drug Patent: AI-Enhanced Protein Treatment Targets $16B Market - Stock Titan
OSR Holdings (OSRH) Sees Strong Pre-Market Gains - Stocks Telegraph
OSR Holdings enters $80 mln stock purchase agreement with White Lion GBM Innovation Fund - MSN
OSR Holdings Signs $80 Million Stock Deal to Support Brain Cancer Research: Shares Up - marketscreener.com
OSR Signs $80 Mln Stock Purchase Agreement With White Lion GBM Innovation Fund, Stock Up - Nasdaq
OSR Holdings secures $80 million funding option for cancer therapy - Investing.com
OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies - digitalmore.co
OSR Holdings Delays Annual Report Filing - TipRanks
Best Biotech Stocks To Follow Today – March 26th - Defense World
3 Penny Stocks to Watch Now, 3/27/25 - TipRanks
OSR Holdings (OSRH) Sees Stock Surge After Positive Trial Results - Stocks Telegraph
Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma - The Malaysian Reserve
Pre-market Movers: OSRH, SURG, BLNE, HUMA, TNON… - RTTNews
Sector Update: Health Care - Marketscreener.com
OSR Unit Vaximm Reports Positive Results for Brain Cancer Therapy; Shares Jump - MarketScreener
Breakthrough in Brain Cancer Treatment: New Trial Data Reveals 11.1-Month Survival Rate - Stock Titan
OSR Holdings names new chief scientific officer By Investing.com - Investing.com South Africa
Bellevue Life Sciences Acquisition Corp. Announces Approval of Business Combination Proposal And Name Change to OSR Holdings, Inc. - The Victoria Advocate
OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer | DigitalMore.co - digitalmore.co
OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer - Marketscreener.com
OSR Holdings names new chief scientific officer - Investing.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
OSRH Stock Plummets to 52-Week Low at $1.31 Amid Market Challenges - Investing.com Canada
OSRH Stock Plummets to 52-Week Low at $1.31 Amid Market Challenges By Investing.com - Investing.com South Africa
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Bellevue Life Sciences Acquisition Corp. Announces Approval of B - GuruFocus.com
OSR Holdings announces $80 million equity agreement with White Lion By Investing.com - Investing.com South Africa
OSR Holdings announces $80 million equity agreement with White Lion - Investing.com
OSR Holdings Ends Shell Status with Share Issuance - TipRanks
Stock market news: MicroAlgo +577.70%, OSR Holdings +46.38% among top gainers during midday trading - Business Upturn
Stock market news: MicroAlgo skyrocketed by 480.87% whereas Mobile-health Network plunged by 42.65% during midday trading - Business Upturn
Stock market today: MicroAlgo +213.92%, GDEV +34.08% among top gainers in early trading - Business Upturn
Why Global Blue Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - NewsBreak
Dow Dips 150 Points; US Housing Starts Fall In January - Benzinga
OSRH Stock Price and Chart — NASDAQ:OSRH - TradingView
Bellevue Life Sciences Acquisition Corp. will Change its Name to OSR Holdings, Inc - marketscreener.com
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.3 million in funding - Marketscreener.com
Stock market today: Asian benchmarks trade mostly higher as investors continue to eye Trump - 69News WFMZ-TV
Japan's economy grows more than expected on strong exports and moderate consumption - 69News WFMZ-TV
US presented Ukraine with a document to access its minerals but offered almost nothing in return - 69News WFMZ-TV
Osr Holdings Inc Stock (OSRH) Financials Data
There is no financial data for Osr Holdings Inc (OSRH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.89%
3.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):